Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial for Oligo-Fucoidan in Cancer Cachexia and Sarcopenia

NCT05623852 is registered in ClinicalTrials.gov with Taipei Medical University WanFang Hospital as lead sponsor.

NCT NCT05623852
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05623852 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial for Oligo-Fucoidan in Cancer Cachexia and Sarcopenia
Lead sponsor
Taipei Medical University WanFang Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
January 30, 2022
Completion date
April 30, 2025
Enrollment
100 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cachexia